On Tuesday, Shares of Procter & Gamble Co (NYSE:PG), lost -1.07% to $68.40.
Members of the American Association of Orthodontists (AAO) are treating more than 5.8 million children, teen-agers and adults in the U.S. and Canada. These orthodontic patients are paying close attention to an important aspect of their treatment: their oral hygiene home care. Crest/Oral-B and the AAO (American Association of Orthodontists) are teaming up to raise awareness about good oral hygiene maintenance for orthodontic patients in addition to the benefits of getting professional services from AAO member orthodontists.
“Orthodontic treatment is a smart investment in good dental health,” according to Morris N. Poole, DDS, president of the AAO. “Good oral hygiene is especially critical during orthodontic treatment. Using the proper oral care products can assist patients keep teeth and gums clean, and enjoy a healthy and beautiful smile when their treatment is complete.”
“Crest/Oral-B is very excited about the partnershipwith the AAO and remains committed to promoting better oral health awareness and making it accessible to consumers,” said Bob Straka, Director of Professional Oral Care, P&G.
Oral-B is the worldwide leader in the over $5 billion brushing market. Part of the Procter & Gamble Company, the brand comprises manual and electric toothbrushes for children and adults, oral irrigators and interdental products, such as dental floss. Oral-B manual toothbrushes are used by more dentists than any other brand in the U.S. and many international markets.
The Procter & Gamble Company, together with its auxiliaries, manufactures and sells branded consumer packaged products worldwide. It operates through five segments: Beauty, Hair and Personal Care; Grooming; Health Care; Fabric Care and Home Care; and Baby, Feminine and Family Care.
Shares of CVS Health Corp (NYSE:CVS), declined -0.12% to $100.09, during its last trading session.
A new survey from CVS/pharmacy released found that nearly two in five U.S. adults (37 percent) have missed a life event because they were feeling ill with flu-like symptoms. The most commonly missed events comprise get-togethers with friends (17 percent), family gatherings (17 percent) and a work meeting or presentation (13 percent).
“No one wants to get sick with the flu, and getting sick is even worse when it causes us to miss an important life event such as a vacation, wedding, holiday gathering or a child’s big sporting event or recital,” said Tom Davis, RPh, Vice President of Pharmacy Professional Practices at CVS/pharmacy. “The simple fact is that getting an annual flu shot is the best protection accessible against catching or spreading the flu.”
“It is recommended to get a flu shot as soon as the vaccine is accessible because it takes a couple of weeks for it to build immunity in order to provide you with the best protection before flu season peaks,” said Nancy Gagliano, Senior Vice President, CVS Health and Chief Medical Officer, CVS/minuteclinic. “You should also get vaccinated every year because influenza strains may change year to year and the vaccines are updated annually.”
Getting the flu shot at CVS/pharmacy or MinuteClinic is also very affordable. Thirty-six percent of Americans who have ever received a flu vaccine indicated that “where their insurance is accepted” is a determining factor for where they get the vaccine administered. The flu vaccine is a preventive service under the Affordable Care Act, fully covered and accessible at no cost through most insurance plans, counting Medicare Part B. CVS/pharmacy and MinuteClinic can directly bill many national and regional health plans that cover all or part of the cost of a flu shot.
CVS/pharmacy, the retail division of CVS Health (CVS), is America’s leading retail pharmacy with over 7,800 locations. It is the first national pharmacy to end the sale of tobacco and the first pharmacy in the nation to receive the Community Pharmacy accreditation from URAC, the leading health care accreditation organization that establishes quality standards for the health care industry.
CVS/minuteclinic is the retail medical clinic of CVS Health (CVS), the largest pharmacy health care provider in the United States. MinuteClinic launched the first retail medical clinics in the United States in 2000 and is the largest provider of retail clinics with nearly 1,000 locations in 31 states and the District of Columbia.
Finally, Kite Pharma Inc (NASDAQ:KITE), ended its last trade with 2.19 % gain, and closed at $50.04.
Kite Pharma Inc, offered an update from the Company’s ongoing Phase 1/2 clinical trial of KTE-C19 in patients with refractory aggressive non-Hodgkin’s lymphoma (NHL) who have failed preceding chemotherapy treatments and have a poor prognosis. KTE-C19 is an investigational therapy in which a patient’s T cells are genetically modified to express a Chimeric Antigen Receptor (CAR) designed to target the antigen CD19, a protein expressed on the cell surface of B-cell lymphomas and leukemias.
“We are encouraged by the progress of the KTE-C19 clinical trial and excited by the responses we have seen so far. We believe the KTE-C19 clinical findings are in line with previous results demonstrating the potential of this promising therapeutic approach,” said Arie Belldegrun, M.D., FACS, Chairman, President and Chief Executive Officer of Kite. “In agreement with ASH, we have taken this exceptional step of providing an update on the trial in order to address recent misinformation in the market related to our clinical program. We are on track to transition to the Phase 2 portion of the trial and plan to present Phase 1 data at ASH later this year.”
Kite Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products. The company is developing a pipeline of engineered autologous cell therapy-based product candidates for the treatment of solid and hematological malignancies.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
